As shown in Figure 3 and Table 4, for the all-cancer endpoints, the HRs of hs-cTnT and NT-proBNP were statistically significant in both minimally adjusted (HR: 1.16; 95% CI: 1.07-1.25; P < 0.001; and HR: 2.53; 95% CI: 1.37-4.67; P = 0.003, respectively) and fully adjusted models (HR: 1.18; 95% CI: 1.09-1.27; P < 0.001; HR: 2.41; 95% CI: 1.30-4.49; P = 0.006, respectively). The gene discussed is TNNT2; the disease is cancer.